Ruxolitinib for treatment of steroid-refractory graft-versus-host disease in adults: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Ruxolitinib for treatment of steroid-refractory graft-versus-host disease in adults: a systematic review and meta-analysis

Published:2020-03-21 Issue:5 Volume:13 Page:565-575
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Hui Li¹^ORCID,Qi Li²,Guoyu Hu¹,Xuliang Shen³⁴,Meiao Tan⁵

Affiliation:

1. Department of Hematology, Zhuzhou Central Hospital, The Affiliated Zhuzhou Hospital of Xiangya Medical College of Central South University, Zhuzhou, Hunan, China

2. Department of Gastroenterology, Shaoyang Hospital of TCM, Shaoyang, Hunan, China

3. Graduate School, Changzhi Medical College, Changzhi, Shanxi, China

4. Department of Hematology, Heping Hospital of Changzhi Medical College, Changzhi, Shanxi, China

5. Graduate School, First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2020.1738214

Reference53 articles.

1. Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failure

2. Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in older adults

3. Allogeneic hematopoietic cell transplantation for myelofibrosis in the era of JAK inhibitors

4. Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis

5. Modern approaches to HLA-haploidentical blood or marrow transplantation

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early Access for Medicines in ITALY: The Case of Ruxolitinib for Patients with Graft-Versus-Host Disease;Journal of Clinical Medicine;2024-07-22

2. Ruxolitinib in Acute and Chronic Graft-Versus-Host Disease: Real Life Long-Term Experience in a Multi-Centre Study for Adult and Pediatric Patients, on Behalf of GETH-TC;2024-07-22

3. Ruxolitinib for the treatment of acute and chronic graft-versus-host disease in children: a systematic review and individual patient data meta-analysis;Bone Marrow Transplantation;2024-02-24

4. Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation;The Lancet Haematology;2024-02

5. When is the best time and grade to start ruxolitinib in corticosteroid‐refractory acute graft‐versus‐host‐disease: A multi‐center research;Clinical Transplantation;2023-11-21